Delivery Order SPE2DR25D3010-SPE2DR26F88AV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,094.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $1,709.46 to supply Dupixent 200 mg/1.14 ml syringes. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $5,189.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml syringes on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,152.11 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $17,075.52 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on November 17, 2025. This firm fixed price delivery order, with an ultimate completion date of November 18, 2025, is a non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $13,785.71 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml syringes on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for conditions including moderate-to-severe atopic...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,074.12 for Dupixent 300 mg/2 mL syringes on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price contract requires delivery to the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a $11,966.22 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $10,256.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes with an ultimate completion date of September 26, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime vendor contract serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $10,777.92 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88AVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,206.04 to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price contract is not set-aside and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. Dupixent (dupilumab) is a biologic medication used to treat various allergic and inflammatory conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis. This delivery order reflects AmerisourceBergen's ongoing role in the Defense Logistics Agency's pharmaceutical supply chain, fulfilling specialized medication requirements for the Defense Health Agency and other federal healthcare systems through competitive, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 11/20/25 |